E-LIB Suche - Ergebnisse für: Bart, Stephan

1

A phase 1, randomized, placebo-controlled, dose-ranging stu..:

Shaw, Christine A. ; August, Allison ; Bart, Stephan...
Vaccine. 41 (2023) 26 - p. 3898-3906 , 2023

2

Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.p..:

Comeaux, Christy A ; Bart, Stephan ; Bastian, Arangassery Rosemary...
The Journal of Infectious Diseases. 229 (2023) 1 - p. 19-29 , 2023

Link: https://doi.org/10.1093/..

3

2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF pr..:

Comeaux, Christy A ; Falsey, Ann R ; Williams, Kristi...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

4

First-in-human study to evaluate safety, tolerability, and ..:

Bockstal, Viki ; Shukarev, Georgi ; McLean, Chelsea...
PLOS ONE. 17 (2022) 10 - p. e0274906 , 2022

Link: https://doi.org/10.1371/..

5

LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based..:

Falsey, Ann R ; Williams, Kristi ; Gymnopoulou, Efi...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S812-S812 , 2021

Link: https://doi.org/10.1093/..

6

Assessments of different batches and dose levels of a two-d..:

Bockstal, Viki ; Gaddah, Auguste ; Goldstein, Neil...
npj Vaccines. 6 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

7

Safety and Tolerability of an Ad26.RSV.preF-based Vaccine i..:

Falsey, Ann ; Williams, Kristi ; Gymnopoulou, Efi...
Innovation in Aging. 5 (2021) Supplement_1 - p. 1045-1045 , 2021

Link: https://doi.org/10.1093/..

8

Safety and Immunogenicity of a Novel Intranasal Influenza V..:

Tasker, Sybil ; Wight O'Rourke, Anna ; Suyundikov, Anvar...
Vaccines. 9 (2021) 3 - p. 224 , 2021

Link: https://doi.org/10.3390/..

9

Phase 2b Study of an Ad26.RSV.preF Vaccine for Prevention o..:

Falsey, Ann ; Williams, Kristi ; Gymnopoulou, Efi...
Innovation in Aging. 5 (2021) Supplement_1 - p. 1042-1042 , 2021

Link: https://doi.org/10.1093/..

10

Impact of smoked cannabis on tobacco cigarette smoking inte..:

Peters, Erica N. ; Herrmann, Evan S. ; Smith, Carson...
Experimental and Clinical Psychopharmacology. 29 (2021) 4 - p. 345-354 , 2021

Link: https://doi.org/10.1037/..

11

A phase 1 randomized safety, reactogenicity, and immunogeni..:

Cartee, Robert T. ; Thanawastien, Ann ; Griffin IV, Thomas J....
PLOS Neglected Tropical Diseases. 14 (2020) 1 - p. e0007912 , 2020

Link: https://doi.org/10.1371/..

12

Safety and Immunogenicity of Heterologous and Homologous 2-..:

Goldstein, Neil ; Bockstal, Viki ; Bart, Stephan...
The Journal of Infectious Diseases. 226 (2020) 4 - p. 595-607 , 2020

Link: https://doi.org/10.1093/..

13

2554. Safety and Immunogenicity of NasoVAX, a Novel Intrana..:

Tasker, Sybil ; Krishnan, Vyjayanthi ; Bart, Stephan...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S68-S68 , 2018

Link: https://doi.org/10.1093/..

14

A phase 1a, first-in-human, randomized study of a respirato..:

Falloon, Judith ; Ji, Fei ; Curtis, Craig...
Vaccine. 34 (2016) 25 - p. 2847-2854 , 2016

Link: https://doi.org/10.1016/..

15

Immunogenicity and safety of a cell culture-based quadrival..:

Bart, Stephan ; Cannon, Kevin ; Herrington, Darrell...
Human Vaccines & Immunotherapeutics. 12 (2016) 9 - p. 2278-2288 , 2016

Link: https://doi.org/10.1080/..